Orange Book product · Generic (ANDA)
DIGOXIN
DIGOXIN
At a glance
Aug 21, 2003
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Aug 21, 2003
23 yr 2 mo ago
Today
Pharmaceutical detail
Active ingredient
DIGOXIN
Strength
0.25MG/ML
Dosage form
INJECTABLE
Route
INJECTION
TE code
AP
Application
ANDA 040481
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of DIGOXIN
- 2004DIGOXINBrand (NDA)
NDA 021648 · HIKMA
- 1997LANOXINBrand (NDA)
NDA 020405 · ADVANZ PHARMA
- 1982LANOXICAPSBrand (NDA)
NDA 018118 · GLAXOSMITHKLINE LLC
- —LANOXINBrand (NDA)
NDA 009330 · AZURITY
- 2022DIGOXINGeneric (ANDA)
ANDA 215307 · NOVITIUM PHARMA
- 2022DIGOXINGeneric (ANDA)
ANDA 215209 · AMICI PHARMA
- 2022DIGOXINGeneric (ANDA)
ANDA 214982 · AUROBINDO PHARMA LTD
- 2019DIGOXINGeneric (ANDA)
ANDA 213000 · VISTAPHARM LLC
- 2009DIGOXINGeneric (ANDA)
ANDA 078556 · IMPAX LABS
- 2007DIGOXINGeneric (ANDA)
ANDA 077002 · HIKMA INTL PHARMS
- 2003DIGOXINGeneric (ANDA)
ANDA 076363 · SUN PHARM INDS INC
- 2002DIGOXINGeneric (ANDA)
ANDA 076268 · STEVENS J
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
